Drug Discovery Informatics Market Forecasts to 2028 – Global Analysis By Solution (Software, Services), Application (Drug Discovery, Drug Development), End User (Biotechnology Companies, Hospital) and By Geography
According to Stratistics MRC, the Global Drug Discovery Informatics market is accounted for $2.24 billion in 2020 and is expected to reach $5.27 billion by 2028 growing at a CAGR of 11.3% during the forecast period. Rising research & development (R&D) expenditure, growing support for research, especially in the area of rare diseases, and the increasing use of informatics in drug discovery are the major factors driving the market growth. However, the scarcity of skilled professionals is restraining the market growth.
Drug Discovery Informatics enables users to address large volume of data storage & management and further processing & analyzing the obtained results. Drug discovery informatics platforms utilize bioinformatics algorithms for processing life science data and uses various in silico models for analyzing the data obtained.
Based on function, the sequencing and target data analysis segment is estimated to have a lucrative growth due to increased application for sequencing analysis for the new drug entity and ease of handling of information from different domains and sources. By geography, North America is going to have high growth during forecast period due to the large share in the global market can be attributed to the presence of well-established contract research organization (CROs), rising R&D expenditure by pharmaceutical and biopharmaceutical companies.
Some of the key players profiled in the Drug Discovery Informatics Market include Albany Molecular Research Inc., Certara, L.P., Charles River, Selvita, Collaborative Drug Discovery, Inc, Dassault Systèmes, GVK Biosciences Private Limited, IBM Corporation, Infosys Limited, Insilico Medicine, IO Informatics, Inc., Jubilant Life Sciences Ltd., OpenEye Scientific Software, PerkinElmer Inc., Schrödinger, LLC and Thermo Fisher Scientific.
Estimated Market Size in 2020:
Compound Annual Growth Rate (CAGR) from 2020 to 2028:
Predicted 2028 Value:
Tables, Graphs & Figures
Type, Solution, Function, Informatics Workflow, Modality, Application, End User and Region
Core Drivers and Opportunities:
Restraining Factors & Market Threats:
• Clinical Trial Data Management
• Library & Database Preparation
• Molecular Modelling
• Screening & Absorption, Distribution, Metabolism, Excretion and Toxicity (ADMET) Characterization
• Sequencing and Target Data Analysis
Informatics Workflows Covered:
• Discovery Informatics
• Development Informatics
• Cloud Based Systems
• In Campus Platform
• Drug Discovery
• Drug Development
End Users Covered:
• Academic Institutes
• Biotechnology Companies
• Contract Research Organization (CROs)
• Government Organizations
• Pharmaceutical Companies
• North America
o Rest of Europe
• Asia Pacific
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2019, 2020, 2021, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Key Questions Answered In The Report
The Global Drug Discovery Informatics Market is majorly driven by rising research & development (R&D) expenditure, growing support for research, especially in the area of rare diseases, and the increasing use of informatics in drug discovery.
The sequencing and target data analysis segment is growing at a highest CAGR owing to increased application for sequencing analysis for the new drug entity and ease of handling of information from different sources and different domains.
North America dominated with a significant market share due to the factors such as presence of well-established CROs, rising R&D expenditure by pharmaceutical and biopharmaceutical companies in the region.
Asia Pacific market is growing at a highest CAGR owing to the rapid growth in the pharmaceutical and biopharmaceutical industry, rising number of CROs, and the presence of less-stringent regulations for drug discovery processes.
Key players in Drug Discovery Informatics Market include Albany Molecular Research Inc., Certara, L.P., Charles River, Selvita, Collaborative Drug Discovery, Inc, Dassault Systèmes, GVK Biosciences Private Limited, IBM Corporation, Infosys Limited, Insilico Medicine, IO Informatics, Inc., Jubilant Life Sciences Ltd., OpenEye Scientific Software, PerkinElmer Inc., Schrödinger, LLC and Thermo Fisher Scientific.
Select License Type
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.